Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 2 minute read Pharma Industry News AstraZeneca strikes $6bn worth deal for Daiichi Sankyo’s DS-1062 AstraZeneca has signed a deal potentially worth up to $6 billion with Daiichi Sankyo for the global development… bypharmanewsdailyJuly 27, 2020
